Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Filed May 4, 2012 · 10-Q · 34 days after period end · 0001367644-12-000025
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $50.31M | $18.53M |
| Net Income | -$6.83M | -$21.40M |
| EPS Diluted | -$0.19 | -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 4, 2012 · 34 d after period end
